Tag: headache

Docs Suffer From Noncompete Clauses: Any Hope for Change?

When Traci Purath, MD, a Wisconsin neurologist, decided to leave the health system where she worked and go into private practice in 2012, she faced...

Novel Therapeutic Target for Depression Identified

An anti-seizure medication appears to reduce anhedonia in patients with depression via a novel mechanism that may offer a new therapeutic target for the disorder,...

Cannabis for Migraine Strongly Linked to Rebound Headache

Patients with chronic migraine who turn to cannabis to relieve headache pain may be setting themselves up for medication overuse headache, preliminary research suggests, although...

Neurologic Disorders Ubiquitous and Rising in the US

Stroke, dementias, and migraine cause the most disability among neurological disorders in the United States, according to new findings derived from the 2017 Global Burden...

Pot May Not Be the Best Rx for a Migraine

MONDAY, March 1, 2021 (HealthDay News) — If you decide to try pot to relieve your migraine, new research suggests you could be asking for...

CDC Chief Signs Off on Advisory Panel’s Backing of J&J Vaccine

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The director of the Centers for Disease Control and Prevention (CDC),...

CDC Warns of Drug-Resistant Typhoid Fever Outbreak

A new drug-resistant strain of Salmonella Typhi has infected least 71 people in the United States, according to the Centers for Disease Control and Prevention....

PFO Closure Reduces Migraine: New Meta-Analysis

A meta-analysis of two randomized studies evaluating patent foramen ovale (PFO) closure as a treatment strategy for migraine has shown significant benefits in several key...

Black COVID-19 Vaccine Hesitancy Rooted in Mistrust, Fear

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Black, Hispanic, and Native American people are about 4 times more...

New NIH Database to Track Neurologic Effects of COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The National Institutes of Health (NIH) has launched a database to...

FDA OKs First Injectable Complete Drug Regimen for HIV

The US Food and Drug Administration (FDA) has approved Cabenuva, an injectable formulation of cabotegravir (Vocabria) and rilpivirine (Edurant), for adults living with HIV-1 infection....

Repeated Ketamine Infusions Linked to Rapid Relief of PTSD

Repeated intravenous infusions of ketamine provide rapid relief for patients with posttraumatic stress disorder (PTSD), new research suggests. In what investigators are calling the first...

Dexamethasone Harmful in Chronic Subdural Hematoma

A commonly used treatment for chronic subdural hematoma appears to be doing more harm than good, a new randomized trial has shown. The results show...

What Happened When the Only ER Doctor in a Rural Town Got COVID

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Kurt Papenfus is the lone full-time emergency room doctor in Cheyenne...

Improvements in Chronic Hand Eczema Seen With Oral Gusacitinib

Gusacitinib, a novel oral inhibitor of multiple inflammatory pathways, achieved rapid and clinically meaningful improvement in corticosteroid-refractory moderate to severe chronic hand eczema in a...

Time to Discuss the Unpleasant Side Effects of COVID Shots?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A health worker injects a woman during clinical trials for a...

Sleep Apnea Found to Impact Pain Severity in Younger Adults

Sleep specialists might want to take a closer look at the connections between obstructive sleep apnea, chronic pain, and reported pain intensity in younger patients....

Delgocitinib Successful for Hand Eczema in Phase 2b Trial

Delgocitinib cream shows a dose-dependent response in easing chronic hand eczema, a common and difficult-to-treat disorder for which few other topical options are available, new...

Pandemic Stress Takes Its Toll

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.   In late March, shortly after New York state closed nonessential...

HIT-6 Helps Track ‘Meaningful Change’ in Chronic Migraine

A more than 6-point improvement in Headache Impact Test (HIT-6) total score and a 1-2 category improvement in item-specific scores of HIT-6 appeared to be...

Positive Topline Results for New Cervical Dystonia Treatment

DaxibotulinumtoxinA for Injection for treatment for cervical dystonia met the primary and all secondary endpoints in the phase 3 ASPEN-1 study, according to topline results...

Once-Weekly Investigational MK-8507 Potent Even at Low Doses

A single dose of MK-8507, an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), reduced HIV-1 viral loads for at least 1 week with efficacy comparable to...

First Confirmed Cases of COVID-19 Reinfections in US

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A 25-year-old man from Nevada and a 42-year-old man in Virginia...

No Migraine ‘Rebound’ Stopping Clopidogrel After ASD Closure

Patients being treated with dual-antiplatelet therapy (DAPT) consisting of clopidogrel plus aspirin following atrial septal defect (ASD) closure can safely discontinue clopidogrel after 3 months...

Multiple Sclerosis Prodrome Holds Promise of Earlier Diagnosis

“It is time that the prodromal phase of multiple sclerosis is formally recognized.” That was the conclusion of Helen Tremlett, PhD, delivering the opening plenary...